HCPLive

Poor Sleep Connected to Obesity, Diabetes, and Heart Disease

Poor Sleep Connected to Obesity, Diabetes, and Heart DiseasePoor sleep is connected to a significantly increased risk for major cardiovascular and metabolic disorders, such as obesity, diabetes, and coronary artery disease, researchers at the University of Pennsylvania’s Perelman School of Medicine have found.

The researchers studied data on 138,201 individuals from the Behavioral Risk Factor Surveillance System, an annual telephone survey carried out by the Centers for Disease Control and Prevention. After adjusting for demographic, socioeconomic, medical, and psychological factors, they found that patients who suffered sleep disturbances at least three nights per week were 35% more likely to be obese, 54% more likely to have diabetes, 98% more likely to have coronary artery disease, 80% more likely to suffer a heart attack, and 102% more likely to have a stroke.

“Previous studies have demonstrated that those who get less sleep are more likely to also be obese, have diabetes or cardiovascular disease, and are more likely to die sooner, but this new analysis has revealed that other sleep problems, such as difficulty falling asleep, staying asleep, or even too much sleep, are also associated with cardiovascular and metabolic health issues,” the study’s lead author, Michael A. Grandner, PhD, said in a press release.

The researchers added that future studies should focus on whether sleep intervention has the potential to reduce the cardiometabolic consequences of sleep disturbance.

The study was published online ahead of print last month in the Journal of Sleep Research.

Most Popular

Recommended Reading

Elderly and frail patients whose blood pressure is also being treated need to be carefully treated, suggest findings published in JAMA Internal Medicine.
Cardiac biomarker testing is often used in emergency department visits even when there is no suspected symptom of acute coronary syndrome, according to research from UT Southwestern Medical Center.
Two days after the US Food and Drug Administration announced that testosterone replacement products must now carry warning labels on the risks of heart attack and stroke, 2 researchers presented abstracts of studies indicating that there is no such danger. The studies were publicized by the American College of Cardiology and will be presented in detail at the group's upcoming meeting in San Diego, CA.
In many states the sale of electronic cigarettes is not as regulated as the more traditional method making it an option for many young potential users.
$vAR$